25642-63-1 Usage
Uses
Used in Chemical Synthesis:
2,6-TOLYLENE DIISOTHIOCYANATE 97 is used as a chemical intermediate for the synthesis of various compounds, including dyes, pharmaceuticals, and agrochemicals. Its reactivity allows for the formation of a wide range of derivatives, making it a valuable building block in the chemical industry.
Used in Analytical Chemistry:
In the field of analytical chemistry, 2,6-TOLYLENE DIISOTHIOCYANATE 97 is used as a derivatizing agent for the detection and analysis of various compounds, such as amines and alcohols. Its ability to form stable derivatives with these compounds enhances their detection and analysis, making it a useful tool in analytical chemistry.
Used in Pharmaceutical Industry:
2,6-TOLYLENE DIISOTHIOCYANATE 97 is used as a key component in the development of new pharmaceuticals, particularly those targeting specific receptors or enzymes. Its unique chemical structure allows for the design of selective and potent drug candidates, contributing to the advancement of drug discovery and development.
Used in Agrochemical Industry:
In the agrochemical industry, 2,6-TOLYLENE DIISOTHIOCYANATE 97 is used as a starting material for the synthesis of various pesticides and herbicides. Its versatility in forming different chemical structures enables the development of effective and targeted agrochemicals, helping to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 25642-63-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,4 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 25642-63:
(7*2)+(6*5)+(5*6)+(4*4)+(3*2)+(2*6)+(1*3)=111
111 % 10 = 1
So 25642-63-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H6N2S2/c1-7-8(10-5-12)3-2-4-9(7)11-6-13/h2-4H,1H3
25642-63-1Relevant academic research and scientific papers
NEW CHEMICAL COMPOUNDS
-
Page/Page column 39, (2008/06/13)
The present invention enco mpasses co mpounds o f general formula (1) wherein R1, M1, L1 and Q are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell prolif
